价格

CD19 CAR-T-cells

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 AND CD20
EP 3240805 B1申请人: UNIV CALIFORNIA优先权: 2014
EP
US
WO
19 件公开
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
US 11207349 B2申请人: CELLULAR BIOMEDICINE GROUP HK LTD优先权: 2020
CN
EP
US
WO
16 件公开
CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19
EP 3149044 B1申请人: US HEALTH优先权: 2014
CN
EP
US
WO
12 件公开
TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
EP 3539986 B1申请人: NOVARTIS AG优先权: 2013
CN
EP
US
WO
11 件公开
Fully human antibody targeting CD19 and application thereof
US 12516117 B2申请人: NANJING IASO BIOTECHNOLOGY CO LTD优先权: 2019
CN
EP
US
WO
7 件公开
CAR T CELLS FOR TREATING CD19+, CD20+ OR CD22+ TUMORS OR B-CELL DERIVED AUTO-IMMUNE DISEASES
EP 4259650 A1申请人: OSPEDALE PEDIATRICO BAMBINO GESÙ优先权: 2020
CN
EP
US
WO
5 件公开
USE OF DUAL-TARGET CAR-T CELLS IN TREATING B-CELL AUTOIMMUNE DISEASES
- EP 4757828 A1
  申请人: GRACELL BIOTECHNOLOGIES SHANGHAI CO LTD优先权: 2023
  CN
  EP
  US
  WO
  4 件公开
- WO 2025030965 A1
  申请人: GRACELL BIOTECHNOLOGIES SHANGHAI CO LTD优先权: 2023
  CN
  WO
  2 件公开
ROR1 CAR or ROR1 / CD19 Dual CAR T Cells for the Treatment of Tumors
US 2024342283 A1申请人: SHANDONG BOAN BIOTECHNOLOGY CO LTD优先权: 2021
CN
US
WO
4 件公开
CHIMERIC ANTIGEN RECEPTORS (CARS) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE
EP 3094653 B1申请人: FORMAN STEPHEN J优先权: 2014
CN
EP
4 件公开
Polynucleotides encoding rituximab-resistant chimeric antigen receptors
US 11896617 B2申请人: ALLOGENE THERAPEUTICS INC优先权: 2020
EP
US
4 件公开

药物

CD19 CAR-T-cells

专利

USE OF DUAL-TARGET CAR-T CELLS IN TREATING B-CELL AUTOIMMUNE DISEASES